Search

Your search keyword '"Grimbaldeston, Michele"' showing total 309 results

Search Constraints

Start Over You searched for: Author "Grimbaldeston, Michele" Remove constraint Author: "Grimbaldeston, Michele"
309 results on '"Grimbaldeston, Michele"'

Search Results

2. Astegolimab, an anti-ST2, in chronic obstructive pulmonary disease (COPD-ST2OP): a phase 2a, placebo-controlled trial

3. Targeting the Human βc Receptor Inhibits Contact Dermatitis in a Transgenic Mouse Model

4. Alternative Splicing Is a Major Factor Shaping Transcriptome Diversity in Mild and Severe COPD

9. Effect of anti-ST2 on blood leukocyte and serum protein levels: insight from a phase IIa, placebo-controlled trial of astegolimab (COPD-ST2OP).

10. A bronchial gene signature specific for severe COPD that is retained in the nose

11. Neutrophil serine protease 4 is required for mast cell-dependent vascular leakage

13. The IgE receptor of mast cells signals mediator release and inflammation via the adaptor protein 14-3-3ζ

19. Effects of inhaled JAK inhibitor GDC-4379 on exhaled nitric oxide and peripheral biomarkers of inflammation

20. Association of bronchial steroid inducible methylation quantitative trait loci with asthma and chronic obstructive pulmonary disease treatment response

23. Su1582: QUANTITATIVE IMMUNOHISTOCHEMICAL ANALYSIS OF IMMUNE CELLS REVEALS IMMUNOPHENOTYPES ASSOCIATED WITH INTESTINAL FIBROSIS AND POSTOPERATIVE STRICTURE RECURRENCE IN CROHN'S DISEASE

24. Late Breaking Abstract - Astegolimab, an anti-ST2, in chronic obstructive pulmonary disease - COPD-ST2OP: a phase IIa, placebo-controlled trial

28. Additional file 3 of Development of an ultra-sensitive human IL-33 biomarker assay for age-related macular degeneration and asthma drug development

29. Additional file 1 of Development of an ultra-sensitive human IL-33 biomarker assay for age-related macular degeneration and asthma drug development

30. Additional file 5 of Development of an ultra-sensitive human IL-33 biomarker assay for age-related macular degeneration and asthma drug development

31. Additional file 1 of Lysophosphatidic acid species are associated with exacerbation in chronic obstructive pulmonary disease

32. Additional file 6 of Development of an ultra-sensitive human IL-33 biomarker assay for age-related macular degeneration and asthma drug development

33. Additional file 2 of Development of an ultra-sensitive human IL-33 biomarker assay for age-related macular degeneration and asthma drug development

34. Additional file 4 of Development of an ultra-sensitive human IL-33 biomarker assay for age-related macular degeneration and asthma drug development

35. High serum granulocyte-colony stimulating factor characterises neutrophilic COPD exacerbations associated with dysbiosis

36. Comparison of genome-wide gene expression profiling by RNA Sequencing versus microarray in bronchial biopsies of COPD patients before and after inhaled corticosteroid treatment: does it provide new insights?

39. RAGE and TLR4 differentially regulate airway hyperresponsiveness: Implications for COPD

42. Determinants of expression of SARS‐CoV‐2 entry‐related genes in upper and lower airways.

46. Genome-wide Analyses of Chromatin State in Human Mast Cells Reveal Molecular Drivers and Mediators of Allergic and Inflammatory Diseases

47. Anti‐β c mAb CSL311 inhibits human nasal polyp pathophysiology in a humanized mouse xenograft model

Catalog

Books, media, physical & digital resources